Renalytix - Total Assets 2020-2024 | RNLXY

Renalytix - total assets from 2020 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Renalytix - Annual Total Assets
(Millions of US $)
2024 $8
2023 $31
2022 $50
2021 $79
2020 $21
2019 $0
2019 $10
Renalytix - Quarterly Total Assets
(Millions of US $)
2024-09-30 $5
2024-06-30 $8
2024-03-31 $9
2023-12-31 $11
2023-09-30 $20
2023-06-30 $31
2023-03-31 $40
2022-12-31 $31
2022-09-30 $39
2022-06-30 $50
2022-03-31 $44
2021-12-31 $54
2021-09-30 $67
2021-06-30 $79
2021-03-31 $85
2020-12-31 $91
2020-09-30 $91
2020-06-30 $21
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $10
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.042B $0.003B
Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Renalytix plc, formerly known as RENALYTIX AI, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.404B 55.40
Tempus AI (TEM) United States $11.811B 0.00
Doximity (DOCS) United States $8.862B 36.49
Hims & Hers Health (HIMS) United States $8.100B 65.89
IRhythm Technologies (IRTC) United States $5.397B 0.00
Hinge Health (HNGE) United States $3.215B 0.00
Privia Health (PRVA) United States $2.856B 178.62
Inspire Medical Systems (INSP) United States $2.466B 40.80
Heartflow (HTFL) United States $2.248B 0.00
10x Genomics (TXG) United States $1.987B 0.00
Enovis (ENOV) United States $1.618B 8.50
Omnicell (OMCL) United States $1.534B 31.37
Azenta (AZTA) United States $1.346B 58.74
Schrodinger (SDGR) United States $1.286B 0.00
Phreesia (PHR) United States $1.234B 0.00
Clover Health Investments (CLOV) United States $1.214B 0.00
Fulgent Genetics (FLGT) United States $0.891B 0.00
Claritev (CTEV) United States $0.630B 0.00
Talkspace (TALK) United States $0.527B 106.00
Veradigm (MDRX) United States $0.517B 0.00
Butterfly Network (BFLY) United States $0.498B 0.00
Standard BioTools (LAB) United States $0.465B 0.00
Evolent Health (EVH) United States $0.432B 0.00
Zepp Health (ZEPP) Netherlands $0.348B 0.00
Carlsmed (CARL) United States $0.327B 0.00
TruBridge (TBRG) United States $0.308B 14.15
SOPHiA GENETICS SA (SOPH) Switzerland $0.274B 0.00
Senseonics Holdings (SENS) United States $0.256B 0.00
CapsoVision (CV) United States $0.248B 0.00
KORU Medical Systems (KRMD) United States $0.208B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.192B 0.00
Nyxoah SA (NYXH) Belgium $0.162B 0.00
Health Catalyst (HCAT) United States $0.158B 0.00
MDxHealth SA (MDXH) Belgium $0.152B 0.00
CareCloud (CCLD) United States $0.132B 7.23
EUDA Health Holdings (EUDA) Singapore $0.103B 0.00
Outset Medical (OM) United States $0.089B 0.00
NetraMark Holdings (AINMF) Canada $0.073B 0.00
American Well (AMWL) United States $0.065B 0.00
Pulmonx (LUNG) United States $0.056B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Evaxion - (EVAX) Denmark $0.043B 0.00
P3 Health Partners (PIII) United States $0.043B 0.00
Precipio (PRPO) United States $0.037B 0.00
111 (YI) China $0.034B 0.00
Lunai Bioworks (LNAI) United States $0.024B 0.00
Predictive Oncology (POAI) United States $0.021B 0.00
Zhongchao (ZCMD) China $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.014B 0.00
Bullfrog AI Holdings (BFRG) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Movano (MOVE) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00